HILORIE GARSIDE: Open Payments
NPI 1649805813 · WEST POINT, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$323 in 18 payments from 10 companies in 2025. Trend: 2023 $385 · 2024 $314 · 2025 $323
Food & beverage: $323
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 6 | $108 |
| ABBVIE INC. | 4 | $76 |
| Phathom Pharmaceuticals, Inc. | 1 | $29 |
| Organon LLC | 1 | $18 |
| Dexcom, Inc. | 1 | $17 |
| Exact Sciences Corporation | 1 | $17 |
| Averitas Pharma Inc. | 1 | $15 |
| Lilly USA, LLC | 1 | $15 |
| Axsome Therapeutics, Inc. | 1 | $15 |
| Astellas Pharma US Inc | 1 | $14 |
Products named: Ozempic, UBRELVY, VOQUEZNA, Rybelsus, VRAYLAR, QULIPTA, NEXPLANON, Dexcom G6 Transmitter.
Industry payments across UT — which companies pay providers there.
